Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

Table 7

Comparison between the reasons for admittance and the type of treatment before and after the admittance between the three groups.

	Group 1		Group 2		Group 3
	Obese		Lean PCOS		Obese PCOS
	n		n		n
Hirsutism	125	4.0%^∧∧∧	92	42.4%	79	35.4%^###
Menstrual disturbances	125	9.6%^∧∧∧	92	75.0%^∗∗	79	49.4%^###
Infertility	125	4.0%	92	4.3%	79	8.9%
Obesity	125	72.0%^∧∧∧	92	4.3%^∗∗∗	79	49.4%^##
Other	124	20.2%^∧	92	9.8%	79	7.6%^#
Mean hospital stay (days)	125	8.42±5.47^∧	94	6.51±4.37	82	7.89±4.78
COC before the admittance	125	4.8%^∧∧∧	92	46.7%^∗∗∗	78	34.6%
Metformin before the admittance	125	10.4%	92	7.6%	78	17.9%^#
Combination of COC and metformin before the admittance	125	0%	92	0%^∗∗	65	7.7%^#
Surgical treatment before the admittance	125	0%^∧∧	92	6.5%^∗∗	78	7.7%
COC after the admittance	125	4.8%^∧∧∧	92	28.3%^∗∗∗	78	28.2%
Metformin after the admittance	125	48.8%	92	44.6%^∗∗∗	78	78.2%^###
Combination of COC and metformin before the admittance	125	1.6%^∧∧∧	92	8.7%^∗∗∗	78	19.2%^#
Surgical treatment after the admittance	125	0%	92	0%	78	0%

^#𝑃<0.05; ^##𝑃<0.01; ^###𝑃<0.001 between group 1 and group 3.
* 𝑃<0.05; **𝑃<0.01; ***𝑃<0.001 between group 2 and group 3.
^∧𝑃<0.05; ^∧∧𝑃<0.01; ^{∧∧ ∧}𝑃<0.001 between group 1 and group 2.
n = number of patients.